A Study of the clinical Utility, patient preference and cost benefit of Spect and PET-CT brain imaging in the Evaluation and Diagnosis of Alzheimer's Disease
Not Applicable
Completed
- Conditions
- Topic: Dementias and Neurodegenerative Diseases Research NetworkDisease: DementiaSubtopic: DementiaMental and Behavioural DisordersAlzheimer's disease
- Registration Number
- ISRCTN49486383
- Lead Sponsor
- orthumberland, Tyne and Wear NHS Trust (UK)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
1. Diagnosis of probable Alzheimer's disease or probable dementia with Lewy bodies or healthy age matched controls
2. Aged over 60 years, either sex
3. Dementia patients to have mild to moderate dementia severity (mini mental state examination [MMSE] greater than 12)
4. Sufficient English to complete cognitive and psychiatric ratings
Exclusion Criteria
1. Physical disability that would render the patient unable to undergo PET and SPECT scanning
2. Contraindications to PET or SPECT scanning
3. Unwillingness to undergo scanning
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method